?????? ????????????????????????? ?????????????? ?? ????.gene in sufferers relapsing just after cure Together with the BCL2 antagonist venetoclax. 66 Resistance to these brokers has been affiliated with these mutations in all over 70% of instances, Whilst they are frequently subclonal as well as their distinct job producing resistance ought to be ve